Registry Progress

Total Number of Patients
Target of 13,150 by Nov 2022
Prospective patient-level data
Surpassed Target of 10,000 by Nov 2022
Published Articles
Target of 21 publications by Dec 2023
Abstracts Accepted
In over 8 international conference

ISAR Newsletter

  • ISAR Country Updates
  • Upcoming Events
  • Publications and Abstracts in 2022
  • Summary of ISAR’s research


Explore the latest high-quality research from ISAR and it’s impact in medical research


Poster and Abstracts

Explore Posters, Abstracts, and Oral Presentations  from ISAR


ISAR Collaborators

We are delighted to have recently welcomed our host-country, Singapore and the innovative teams from Poland and Sweden to the ISAR family! The expertise we have gained from our newest collaborators, from both primary and specialist care will help us to improve outcomes for patients with severe and potentially severe asthma now and well into the future. May our newest collaborations be far-reaching and successful for all those involved!

Agreements Executed

Australia, Bulgaria, Canada, Colombia, Denmark, Greece, India, Ireland, Italy, Japan, Kuwait, Mexico, Poland, Portugal, Saudi Arabia, Singapore, Spain, South Korea, Sweden, Taiwan, UAE, UK, USA

Agreements in Progress

Belgium, Brazil, Estonia, Finland, France, Germany, Hungary, Iceland, Norway

ISAR collaborators Placeholder
ISAR collaborators

Agreements executed

Agreements in Progress

The International Severe Asthma Registry is a global collaborative initiative to gather anonymous, longitudinal, real-life data for patients with severe asthma from 25 countries. ISAR offers a rich source of real-life data for scientific research to understand and improve symptoms, treatments, and patient outcomes for severe asthma. The database will also provide an international platform for research collaboration in respiratory medicine and patient care.

Latest News